[
    [
        {
            "time": "",
            "original_text": "康泰生物(300601.SZ)：控股股东及其一致行动人持股比例被稀释2.18% 降至51.59%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "控股股东",
                    "一致行动人",
                    "持股比例",
                    "稀释"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)：控股股东及其一致行动人持股比例被稀释2.18% 降至51.59%",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【医药】四月份疫苗批签发：高端产品批签发比重不断加大——医药行业专题报告——中性（联系人：甘英健、陈晨、张山峰）",
            "features": {
                "keywords": [
                    "医药",
                    "疫苗",
                    "批签发",
                    "高端产品",
                    "比重加大"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】四月份疫苗批签发：高端产品批签发比重不断加大——医药行业专题报告——中性（联系人：甘英健、陈晨、张山峰）",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]